Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
A novel mouse model for cardiovascular-kidney-metabolic syndrome: Bridging metabolic, renal and cardiac dysfunction
Molecular Metabolism
June 2026
van Koppen A.
Open Access
Casein- and Soy-Based High-Protein Diets Differentially Affect Insulin Resistance and Adipose Tissue Advanced Glycation End Product Accumulation in Obese Diabetic Mice
Current Developments in Nutrition
March 2026
Shiraga Y.
Open Access
Longitudinal changes in the gut microbiota with the progression of obesity-associated type 2 diabetes in KK-Ay mice
Bioscience of Microbiota Food and Health
2026
Yasui M.
Open Access
Research and advances in mouse models of diabetic nephropathy: a narrative review
BMC Nephrology
December 2025
Xie K.
Open Access
miR-214 and Its Primary Transcript Dnm3os Regulate Fibrosis and Inflammation Through RAGE Signaling in Diabetic Kidney Disease
Diabetes
July 2025
Hagiwara S.
Open Access
Targeting PKCα alleviates iron overload in diabetes and hemochromatosis through the inhibition of ferroportin
Blood
26 September 2024
Banerjee S.
Open Access
Diabetic Kidney Disease: Contribution of Phenyl Sulfate Derived from Dietary Tyrosine upon Gut Microbiota Catabolism
Biomolecules
September 2024
Liu H.
Open Access
A Review of Animal Models for Studying Bone Health in Type-2 Diabetes Mellitus (T2DM) and Obesity
International Journal of Molecular Sciences
September 2024
Norazman S.I.
Open Access
Progress in experimental models to investigate the in vivo and in vitro antidiabetic activity of drugs
Animal Models and Experimental Medicine
June 2024
Janapati Y.K.
Open Access
A pan-PPAR agonist E17241 ameliorates hyperglycemia and diabetic dyslipidemia in KKAy mice via up-regulating ABCA1 in islet, liver, and white adipose tissue
Biomedicine and Pharmacotherapy
March 2024
Sheng R.
Open Access
E-Stilbenes: General Chemical and Biological Aspects, Potential Pharmacological Activity Based on the Nrf2 Pathway
Pharmaceuticals
February 2024
Mendonça E.L.S.S.
Open Access
Cognitive dysfunction and increased phosphorylated tau are associated with reduced O-GlcNAc signaling in an aging mouse model of metabolic syndrome
Journal of Neuroscience Research
August 2023
Gupta S.
Open Access
Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles
Journal of Ethnopharmacology
1 March 2023
Zhou R.
Pharmacogenomics in autoimmune diseases
Pharmacogenomics from Discovery to Clinical Implementation
1 January 2023
Shafique F.
Apolipoprotein A-IV reduced metabolic inflammation in white adipose tissue by inhibiting IKK and JNK signaling in adipocytes
Molecular and Cellular Endocrinology
1 January 2023
Liu X.H.
Effects of salt supplementation in uninephrectomized KK-Ay mice: Examining the potential of a diabetic kidney disease model
Journal of Toxicological Sciences
2023
Sano R.
Open Access
A user-friendly tool for cloud-based whole slide image segmentation with examples from renal histopathology
Communications Medicine
December 2022
Lutnick B.
Open Access
Could consumption of yam (Dioscorea) or its extract be beneficial in controlling glycaemia: A systematic review
British Journal of Nutrition
28 August 2022
Alharazi W.Z.
Open Access
Guidelines on models of diabetic heart disease
American Journal of Physiology Heart and Circulatory Physiology
July 2022
Heather L.C.
Open Access
PodoCount: A Robust, Fully Automated, Whole-Slide Podocyte Quantification Tool
Kidney International Reports
June 2022
Santo B.A.
Open Access
Experimental animal models for diabetes and its related complications—a review
Laboratory Animal Research
December 2021
Kottaisamy C.P.D.
Open Access
Antidiabetic effect of taxifolin in cultured l6 myotubes and type 2 diabetic model kk-ay/ta mice with hyperglycemia and hyperuricemia
Current Issues in Molecular Biology
December 2021
Kondo S.
Open Access
Toxicokinetics of methylmercury in diabetic KK-Ay mice and C57BL/6 mice
Journal of Applied Toxicology
June 2021
Yamamoto M.
Sacubitril/valsartan treatment has differential effects in modulating diabetic kidney disease in db/db mice and KKAy mice compared with valsartan treatment
American Journal of Physiology Renal Physiology
June 2021
Myakala K.
All Open Access, Green